API | |||||
| Executive standards | Compliance | |||
Drugs for senile dementia | ... | SFDA | EQDM | FDA | |
Idebenone | Enterprise standard | GMP | |||
Donepezil Hydrochloride | Enterprise standard | ||||
Cardiovascular medicine | |||||
Indapamide | BP2007,USP31,EP6th | GMP | Pre-registration | ||
Hydrochlorothiazide | BP2007,USP31,EP6th | GMP | DMF | ||
Bumetanide | EP6th | ||||
Chlorothiazide | BP2007,USP31 | ||||
Clopidogrel Bisulfate | USP31 | Pre-registration | |||
Ritodrine Hydrochloride | USP31 | ||||
Antineoplastic medicine | |||||
Dacarbazine | BP2007,USP31,EP6th | GMP | Pre-registration | ||
Pemetrexed disodium | USP31 | ||||
Oxaliplatin | EP6th | Pre-registration | Pre-registration | DMF | |
Pharmaceutic Adjuvant | |||||
Cellulose Acetate Phthalate | BP2007, USP31 | ||||
Others | |||||
Acrivastine | BP2007,USP31,EP6th |
|
|
| |
Products Intermediate | |
API | Related intermediate |
Idebenone | 6-(10-Hydroxyxdecanoyl)-2,3-Dimethoxy-5-Methylphenol |
Hydrochlorothiazide | 4-Amino-6-Chloro-1,3-Benzenedisulfonamide |
Indapamide | 1-amino-2-methylindoline hydrochloride |
4-chloro-3-sulfamoylbenzoyl chloride | |
Bumetanide | 4-chloro-5-nitro-3-chlorosulfonybenzoic acid |
4-chloro-5-nitro-3-sulphamoylbenzoic acid | |
Ritodrine Hydrochloride | 2-bromo-4-benzyloxypropiophenone |
Donepezil Hydrochloride | 5,6-dimethoxy-1-indanone.. |
Clopidogrel | (S)-(+)-2-Chlorophenylglycine methyl ester hydrochloride |
Pemetrexed disodium | 4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin -5-yl)ethyl]benzoic acid |
Methyl-phenidate | Phenyl-(2-piperidinyl)acetic acid; alpha-Phenylpiperidine-2-acetic acid; 2-Phenyl-2-(2-piperidyl)acetic acid. |